Purdue opioid settlement gets backing from 55 attorneys generalnews2025-06-16T19:33:33+00:00June 16th, 2025|Endpoints News|
Eli Lilly makes all Zepbound doses available in single-dose vials news2025-06-16T19:04:47+00:00June 16th, 2025|Endpoints News|
AbbVie’s Venclexta fails Phase 3 study in other bone marrow cancersnews2025-06-16T15:25:26+00:00June 16th, 2025|Endpoints News|
KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’ news2025-06-13T20:42:05+00:00June 13th, 2025|Endpoints News|
FDA’s oncology adcomm to review GSK’s Blenrep relaunch plansnews2025-06-13T18:16:00+00:00June 13th, 2025|Endpoints News|
With HIV prevention under attack, how might Gilead’s new PrEP injection fare?news2025-06-13T14:30:31+00:00June 13th, 2025|Endpoints News|
Moderna wins FDA approval for expanded use of RSV shot in more adultsnews2025-06-13T00:22:16+00:00June 13th, 2025|Endpoints News|
Appeals court upholds halt on Minnesota generic drug pricing lawnews2025-06-12T19:09:42+00:00June 12th, 2025|Endpoints News|
Novo Nordisk plans Phase 3 trials of oral, injectable amycretinnews2025-06-12T19:00:27+00:00June 12th, 2025|Endpoints News|
Kennedy’s doubts over vaccine placebos don’t align with science, experts saynews2025-06-12T18:52:39+00:00June 12th, 2025|Endpoints News|
